Published in Am J Drug Alcohol Abuse on January 01, 2002
The reinstatement model and relapse prevention: a clinical perspective. Psychopharmacology (Berl) (2003) 1.43
Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications. Expert Opin Investig Drugs (2013) 0.89
Bupropion: a review of its mechanism of antidepressant activity. J Clin Psychiatry (1995) 3.30
A randomized trial of bromocriptine for cocaine users presenting to the emergency department. J Gen Intern Med (1993) 2.71
Assessment of cocaine use with quantitative urinalysis and estimation of new uses. Addiction (1997) 1.79
Bupropion reduces cocaine abuse in methadone-maintained patients. Arch Gen Psychiatry (1991) 1.53
Incidence of seizures during treatment with tricyclic antidepressant drugs and bupropion. J Clin Psychiatry (1983) 1.07
Interpersonal psychotherapy adapted for ambulatory cocaine abusers. Am J Drug Alcohol Abuse (1985) 0.99
Double-blind comparison of bromocriptine and placebo in cocaine withdrawal. Am J Drug Alcohol Abuse (1995) 0.85
Current status of dopamine agonists in Parkinson's disease management. Drugs (1993) 0.85
A Treatment Algorithm for Attention Deficit Hyperactivity Disorder in Cocaine-Dependent Adults: A One-Year Private Practice Study with Long-Acting Stimulants, Fluoxetine, and Bupropion. Subst Abus (1999) 0.83
Dopamine agonists. Med Clin North Am (1999) 0.82
Management of alcohol withdrawal delirium. An evidence-based practice guideline. Arch Intern Med (2004) 4.55
Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure. Psychopharmacology (Berl) (2006) 4.23
Why should addiction medicine be an attractive field for young physicians? Addiction (2008) 3.52
Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in clinical trials. Addiction (2011) 3.42
Introduction to behavioral addictions. Am J Drug Alcohol Abuse (2010) 3.22
Real-time electronic diary reports of cue exposure and mood in the hours before cocaine and heroin craving and use. Arch Gen Psychiatry (2009) 2.95
Global surveillance of emerging Influenza virus genotypes by mass spectrometry. PLoS One (2007) 2.29
Use of a 'microecological technique' to study crime incidents around methadone maintenance treatment centers. Addiction (2012) 2.20
Availability of rapid human immunodeficiency virus testing in academic emergency departments. Acad Emerg Med (2008) 2.17
Cognitive-behavioral therapy plus contingency management for cocaine use: findings during treatment and across 12-month follow-up. Psychol Addict Behav (2003) 1.94
Cannabis withdrawal among non-treatment-seeking adult cannabis users. Am J Addict (2006) 1.94
The Fagerstrom Test for Nicotine Dependence and the Diagnostic Interview Schedule: do they diagnose the same smokers? Addict Behav (2002) 1.74
Cannabinoids in exhaled breath following controlled administration of smoked cannabis. Clin Chem (2013) 1.67
Cocaine craving and use during daily life. Psychopharmacology (Berl) (2009) 1.62
Nomenclature and definitions for emergency department human immunodeficiency virus (HIV) testing: report from the 2007 conference of the National Emergency Department HIV Testing Consortium. Acad Emerg Med (2008) 1.62
On-site test for cannabinoids in oral fluid. Clin Chem (2012) 1.57
Tobacco, cocaine, and heroin: Craving and use during daily life. Addict Behav (2009) 1.56
Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence. Clin Pharmacol Ther (2004) 1.46
Incubation of cue-induced cigarette craving during abstinence in human smokers. Biol Psychiatry (2011) 1.44
The reinstatement model and relapse prevention: a clinical perspective. Psychopharmacology (Berl) (2003) 1.43
The future of endocannabinoid-oriented clinical research after CB1 antagonists. Psychopharmacology (Berl) (2009) 1.42
Reliability and validity of a short form of the Marijuana Craving Questionnaire. Drug Alcohol Depend (2009) 1.42
Update on Emerging Infections: News From the Centers for Disease Control and Prevention. Ann Emerg Med (2016) 1.40
Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers. Drug Alcohol Depend (2010) 1.39
Questions on conflict of interest. Am J Psychiatry (2010) 1.38
Abuse liability, behavioral pharmacology, and physical-dependence potential of opioids in humans and laboratory animals: lessons from tramadol. Biol Psychol (2006) 1.34
Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users. Psychopharmacology (Berl) (2007) 1.32
Changes in HIV risk behaviors among patients receiving combined pharmacological and behavioral interventions for heroin and cocaine dependence. Addict Behav (2005) 1.31
Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults. Ther Drug Monit (2008) 1.29
A factor analysis of the Fagerström Test for Nicotine Dependence (FTND). Nicotine Tob Res (2003) 1.28
Rapid identification of biothreat and other clinically relevant bacterial species by use of universal PCR coupled with high-resolution melting analysis. J Clin Microbiol (2009) 1.28
Delta9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC plasma pharmacokinetics during and after continuous high-dose oral THC. Clin Chem (2009) 1.28
Wireless sensing systems in clinical environments: improving the efficiency of the patient monitoring process. IEEE Eng Med Biol Mag (2010) 1.25
Quitting among non-treatment-seeking marijuana users: reasons and changes in other substance use. Am J Addict (2006) 1.21
Daily life hour by hour, with and without cocaine: an ecological momentary assessment study. Psychopharmacology (Berl) (2010) 1.21
Effect of rate of administration on subjective and physiological effects of intravenous cocaine in humans. Drug Alcohol Depend (2005) 1.20
Disposition of cannabinoids in oral fluid after controlled around-the-clock oral THC administration. Clin Chem (2010) 1.19
Identification of recent cannabis use: whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration. Clin Chem (2011) 1.18
Phase I and II cannabinoid disposition in blood and plasma of occasional and frequent smokers following controlled smoked cannabis. Clin Chem (2014) 1.15
Rapid identification of bacterial pathogens in positive blood culture bottles by use of a broad-based PCR assay coupled with high-resolution melt analysis. J Clin Microbiol (2010) 1.14
Mechanical properties of retrieved highly cross-linked crossfire liners after short-term implantation. J Arthroplasty (2005) 1.13
Are We There Yet? Feasibility of Continuous Stress Assessment via Wireless Physiological Sensors. ACM BCB (2015) 1.12
HIV testing in emergency departments in the United States: a national survey. Ann Emerg Med (2011) 1.12
Clonidine blocks stress-induced craving in cocaine users. Psychopharmacology (Berl) (2011) 1.12
Promoting abstinence from cocaine and heroin with a methadone dose increase and a novel contingency. Drug Alcohol Depend (2008) 1.11
Cannabinoid disposition in oral fluid after controlled smoked cannabis. Clin Chem (2012) 1.09
Effects of the cannabinoid-1 receptor antagonist rimonabant on psychiatric symptoms in overweight people with schizophrenia: a randomized, double-blind, pilot study. J Clin Psychopharmacol (2011) 1.08
Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection. Drug Alcohol Depend (2003) 1.08
Heroin and cocaine craving and use during treatment: measurement validation and potential relationships. J Subst Abuse Treat (2006) 1.08
State of the art treatments for cannabis dependence. Psychiatr Clin North Am (2012) 1.07
Calorie restriction increases cigarette use in adult smokers. Psychopharmacology (Berl) (2004) 1.06
The second-oldest state psychiatric hospital in the United States. Am J Psychiatry (2014) 1.06
Randomized trial of prize-based reinforcement density for simultaneous abstinence from cocaine and heroin. J Consult Clin Psychol (2007) 1.06
Brain mu-opioid receptor binding predicts treatment outcome in cocaine-abusing outpatients. Biol Psychiatry (2010) 1.05
Pharmacological treatment of cannabis dependence. Curr Pharm Des (2011) 1.04
Cannabinoid disposition in oral fluid after controlled cannabis smoking in frequent and occasional smokers. Drug Test Anal (2014) 1.03
Physiological and subjective responses to controlled oral 3,4-methylenedioxymethamphetamine administration. J Clin Psychopharmacol (2008) 1.01
The cannabinoid CB1 receptor antagonist rimonabant attenuates the hypotensive effect of smoked marijuana in male smokers. Am Heart J (2006) 1.01
Major and minor metabolites of cocaine in human plasma following controlled subcutaneous cocaine administration. J Anal Toxicol (2006) 1.01
Strategies for quitting among non-treatment-seeking marijuana smokers. Am J Addict (2005) 1.00
Differentiating new cannabis use from residual urinary cannabinoid excretion in chronic, daily cannabis users. Addiction (2010) 0.98
Sociodemographic characteristics of cannabis smokers and the experience of cannabis withdrawal. Am J Drug Alcohol Abuse (2010) 0.98
Cannabinoids and metabolites in expectorated oral fluid following controlled smoked cannabis. Clin Chim Acta (2012) 0.97
Conditional substance abuse and dependence by diagnosis of mood or anxiety disorder or schizophrenia in the U.S. population. Drug Alcohol Depend (2011) 0.97
Very low dose naltrexone addition in opioid detoxification: a randomized, controlled trial. Addict Biol (2008) 0.96
Marriage and relationship closeness as predictors of cocaine and heroin use. Addict Behav (2008) 0.96
Cannabinoid stability in authentic oral fluid after controlled cannabis smoking. Clin Chem (2012) 0.95
Longitudinal ECG changes in cocaine users during extended abstinence. Drug Alcohol Depend (2008) 0.95
A dose response study of cognitive behavioral therapy in cocaine abusers. J Subst Abuse Treat (2002) 0.95
Opioid challenge evaluation of blockade by extended-release naltrexone in opioid-abusing adults: dose-effects and time-course. Drug Alcohol Depend (2011) 0.95
Contingency management reduces injection-related HIV risk behaviors in heroin and cocaine using outpatients. Addict Behav (2007) 0.94
Hepatitis C and human immunodeficiency virus risk behaviors in polydrug users on methadone maintenance. J Subst Abuse Treat (2007) 0.94
Psychomotor performance, subjective and physiological effects and whole blood Δ⁹-tetrahydrocannabinol concentrations in heavy, chronic cannabis smokers following acute smoked cannabis. J Anal Toxicol (2012) 0.93
Nonreporting of cannabis use: Predictors and relationship to treatment outcome in methadone maintained patients. Addict Behav (2006) 0.93
Computer-facilitated rapid HIV testing in emergency care settings: provider and patient usability and acceptability. AIDS Educ Prev (2011) 0.92
Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers. Anal Bioanal Chem (2013) 0.91
Psychosocial functioning and cocaine use during treatment: strength of relationship depends on type of urine-testing method. Drug Alcohol Depend (2007) 0.90
Adverse events among patients in a behavioral treatment trial for heroin and cocaine dependence: effects of age, race, and gender. Drug Alcohol Depend (2005) 0.90
Intravenous butyrylcholinesterase administration and plasma and brain levels of cocaine and metabolites in rats. Eur J Pharmacol (2005) 0.90
Public health in the emergency department: surveillance, screening, and intervention--funding and sustainability. Acad Emerg Med (2009) 0.90
Cannabinoids and metabolites in expectorated oral fluid after 8 days of controlled around-the-clock oral THC administration. Anal Bioanal Chem (2011) 0.90
Urinary cannabinoid disposition in occasional and frequent smokers: is THC-glucuronide in sequential urine samples a marker of recent use in frequent smokers? Clin Chem (2013) 0.89
Rimonabant for neurocognition in schizophrenia: a 16-week double blind randomized placebo controlled trial. Schizophr Res (2011) 0.89
EEG absolute power during extended cocaine abstinence. J Addict Med (2007) 0.89
Assessment of agonist and antagonist effects of tramadol in opioid-dependent humans. Exp Clin Psychopharmacol (2006) 0.87
Synthetic cannabinoids pharmacokinetics and detection methods in biological matrices. Drug Metab Rev (2015) 0.87
Effect of reinforcement probability and prize size on cocaine and heroin abstinence in prize-based contingency management. J Appl Behav Anal (2008) 0.87
Oral fluid and plasma cannabinoid ratios after around-the-clock controlled oral Δ(9)-tetrahydrocannabinol administration. Clin Chem (2011) 0.86
Motivations to quit cannabis use in an adult non-treatment sample: are they related to relapse? Addict Behav (2013) 0.86
Effects of high-dose intravenous buprenorphine in experienced opioid abusers. J Clin Psychopharmacol (2004) 0.86
Reverse transcription-PCR-electrospray ionization mass spectrometry for rapid detection of biothreat and common respiratory pathogens. J Clin Microbiol (2013) 0.85
Spending of remuneration by subjects in non-treatment drug abuse research studies. Am J Drug Alcohol Abuse (2006) 0.85
Sex differences in cocaine/heroin users: drug-use triggers and craving in daily life. Drug Alcohol Depend (2013) 0.85
Self-report of illicit benzodiazepine use on the Addiction Severity Index predicts treatment outcome. Drug Alcohol Depend (2008) 0.85
Cannabis withdrawal in chronic, frequent cannabis smokers during sustained abstinence within a closed residential environment. Am J Addict (2014) 0.84
Influence of psychotherapy attendance on buprenorphine treatment outcome. J Subst Abuse Treat (2005) 0.84
In vitro stability of free and glucuronidated cannabinoids in urine following controlled smoked cannabis. Anal Bioanal Chem (2013) 0.84